copper histidinate; copper bis(histidinate) (CUTX-101, Zycubo)
Jump to navigation
Jump to search
Indications
- treatment of Menkes disease (FDA_approved)
Dosage
References
- ↑ Reuters US FDA approves Fortress Bio and Zydus' treatment for a rare pediatric disease. January 13, 2026 https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-fortress-bio-zydus-treatment-rare-pediatric-disease-2026-01-13/
AMA Morning Report. Jan 14, 2026 American Medical Association